Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease

Anton Rahmadi1 / Nicole Steiner1 / 1

1Department of Pharmacology, School of Medicine, University of Western Sydney, Campbelltown, Australia

Corresponding author: Associate Professor Gerald Münch, Department of Pharmacology, School of Medicine, University of Western Sydney, Locked Bag 1797, Penrith South DC, NSW 1797, Australia Phone: +61 2 9852 4718, Fax: +61 2 9852 4730

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 49, Issue 3, Pages 385–391, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2011.079, January 2011

Publication History

Received:
2010-08-30
Accepted:
2010-10-25
Published Online:
2011-01-31

Abstract

Alzheimer's disease (AD) is the most common dementia disorder of later life. Although there might be various different triggering events in the early stages of the disease, they appear to converge on a few characteristic final pathways in the late stages, characterized by inflammation and neurodegeneration. Here, we review the hypothesis that advanced glycation end products (AGEs), which reflect carbonyl stress, an imbalance between the production of reactive carbonyl compounds and their detoxification, can serve as biomarkers for the progression of disorder. AGE modification may explain many of the neuropathological and biochemical features of AD, such as extensive protein cross-linking shown as amyloid plaques and neurofibrillary tangles, inflammation, oxidative stress and neuronal cell death. Although accumulation of AGEs is a normal feature of aging, it appears to be significantly accelerated in AD. We suggest that higher AGE concentrations in brain tissue and in cerebrospinal fluid might be able to distinguish between normal aging and AD.

Keywords: advanced glycation end products; Alzheimer's disease; carbonyl stress; gerontotoxins; methylglyoxal

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Cristina Angeloni, Marco Malaguti, Benedetta Rizzo, Maria Cristina Barbalace, Daniele Fabbri, and Silvana Hrelia
Chemical Research in Toxicology, 2015, Volume 28, Number 6, Page 1234
[2]
E. Bigagli, C. Luceri, T. Scartabelli, P. Dolara, F. Casamenti, D. E. Pellegrini-Giampietro, and L. Giovannelli
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2015
[3]
Suzanne M. de la Monte and Ming Tong
Biochemical Pharmacology, 2014, Volume 88, Number 4, Page 548
[4]
James D. Weinstein, Edgar R. Gonzalez, Richard D. Egleton, and David A. Hunt
The Consultant Pharmacist, 2013, Volume 28, Number 7, Page 443
[5]
Dhanushka Gunawardena, Kirubakaran Shanmugam, Mitchell Low, Louise Bennett, Suresh Govindaraghavan, Richard Head, Lezanne Ooi, and Gerald Münch
European Journal of Nutrition, 2014, Volume 53, Number 1, Page 335
[6]
Yukiko Nakajima, Yuji Inagaki, Yuka Hiroshima, Jun-ichi Kido, and Toshihiko Nagata
Journal of Endodontics, 2013, Volume 39, Number 7, Page 873
[7]
Stig Bengmark
Pharmacological Research, 2013, Volume 69, Number 1, Page 87
[8]
Dora Il'yasova, Peter Scarbrough, and Ivan Spasojevic
Clinica Chimica Acta, 2012, Volume 413, Number 19-20, Page 1446
[9]
Zhenlie Huang, Sahoko Ichihara, Shinji Oikawa, Jie Chang, Lingyi Zhang, Kaviarasan Subramanian, Sahabudeen Sheik Mohideen, and Gaku Ichihara
Toxicology and Applied Pharmacology, 2012, Volume 263, Number 1, Page 44
[10]
Jinlong Li, Danian Liu, Ling Sun, Yunting Lu, and Zhongling Zhang
Journal of the Neurological Sciences, 2012, Volume 317, Number 1-2, Page 1

Comments (0)

Please log in or register to comment.